SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-17-000030
Filing Date
2017-06-13
Accepted
2017-06-13 16:09:09
Documents
3
Period of Report
2017-06-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20170613x8k.htm 8-K 39294
2 EX-99.1 bpmx-20170613ex99158c060.htm EX-99.1 190723
3 GRAPHIC bpmx20170613ex99158c060001.jpg GRAPHIC 73358
  Complete submission text file 0001504167-17-000030.txt   332365
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 17908922
SIC: 2834 Pharmaceutical Preparations